Complete list of 69 Drug Manufacturers - General industry stocks with AI-powered MoonshotScore analysis, real-time price data, and institutional-grade market insights. Part of the Healthcare sector.
The Drug Manufacturers - General industry, part of the Healthcare sector, comprises 69 publicly traded companies with a combined market capitalization of $6.0T. This includes 9 mega-cap companies (over $200B), reflecting the industry's significant weight in global markets.
Today's market sentiment for Drug Manufacturers - General stocks is Bearish, with 16 stocks advancing and 23 declining. The average price movement across the industry is -2.08%.
The average AI MoonshotScore across Drug Manufacturers - General stocks is 56/100, indicating above-average growth potential based on our proprietary analysis combining fundamentals, technicals, and sentiment.
How Drug Manufacturers - General companies are distributed across market capitalization tiers.
There are currently 69 publicly traded companies classified under the Drug Manufacturers - General industry within the Healthcare sector.
Based on our AI MoonshotScore analysis, the top-rated Drug Manufacturers - General stocks are CRXTQ, LLY, MRK. Always conduct your own research before investing.
The largest Drug Manufacturers - General companies by market capitalization are LLY (854B), BMYMP ($814.59B), JNJ (586B).
The current average MoonshotScore for the Drug Manufacturers - General industry is 56/100.
Drug Manufacturers - General stocks are tracked against broader market benchmarks. You can compare sector and industry performance on our Market Sectors dashboard.
Stock Expert AI evaluates every publicly traded U.S. stock using the MoonshotScore, a proprietary 0–100 composite rating. The score synthesizes nine quantitative dimensions: revenue growth trajectory, profitability and margins, analyst consensus estimates, insider transaction patterns, institutional ownership shifts, short interest dynamics, technical momentum signals, earnings surprise history, and valuation multiples relative to peers.
Price data is sourced from Financial Modeling Prep (FMP) with Yahoo Finance as a fallback. Fundamental data comes from SEC filings, FMP, and Alpha Vantage. Sentiment signals are derived from aggregated analyst ratings and news flow. All metrics refresh during market hours; after-hours data reflects the most recent closing values.
Sector and industry classifications follow the Global Industry Classification Standard (GICS), the same taxonomy used by S&P and MSCI. Companies are assigned to one of 11 sectors and further classified into 50+ industries based on their primary revenue source.
Data is provided for informational purposes only and should not be considered investment advice. Stock prices, market capitalizations, and MoonshotScores are updated throughout the trading day. Past performance does not guarantee future results. Always consult with a qualified financial advisor before making investment decisions.
| Stock | Price | Change | Volume | Market Cap | MoonshotScore | Sector |
|---|---|---|---|---|---|---|
|
CRXTQ
Clarus Therapeutics Holdings, Inc.
|
$0.00 | +0.00% | 38.26K | $72.83K | 68 | Healthcare |
|
LLY
Eli Lilly and Company
|
$903.40 | -1.41% | 2M | 854B | 67 | Healthcare |
|
MRK
Merck & Co., Inc.
|
$117.61 | -1.69% | 5M | 291B | 64 | Healthcare |
|
ORINY
Orion Oyj
|
$37.99 | +0.00% | 6 | $21.37B | 64 | Healthcare |
|
ORINF
Orion Oyj
|
$82.75 | +4.81% | 100 | $11.64B | 63 | Healthcare |
|
GSK
GSK plc
|
$53.94 | -1.39% | 5M | 109B | 61 | Healthcare |
|
AZN
AstraZeneca PLC
|
$187.14 | +0.73% | 2M | 146B | 61 | Healthcare |
|
AZNCF
AstraZeneca PLC
|
$189.90 | -1.35% | 1.43M | $294.40B | 60 | Healthcare |
|
BIIB
Biogen Inc.
|
$177.34 | +0.99% | 1.30M | $26.03B | 59 | Healthcare |
|
OPHLF
Ono Pharmaceutical Co., Ltd.
|
$14.55 | +0.00% | 120 | $6.84B | 59 | Healthcare |
|
AMGN
Amgen Inc.
|
$347.80 | -0.61% | 10M | 188B | 59 | Healthcare |
|
OTSKF
Otsuka Holdings Co., Ltd.
|
$72.22 | +2.67% | 359 | $38.14B | 58 | Healthcare |
|
PFE
Pfizer Inc.
|
$26.45 | +2.32% | 52M | 151B | 58 | Healthcare |
|
ALPMF
Astellas Pharma Inc.
|
$16.36 | -7.07% | 5.01K | $29.30B | 58 | Healthcare |
|
SNY
Sanofi
|
$46.62 | +1.28% | 3M | 114B | 58 | Healthcare |
|
GLAXF
GSK plc
|
$26.55 | -0.75% | 256 | $106.20B | 58 | Healthcare |
|
OTSKY
Otsuka Holdings Co., Ltd.
|
$35.19 | -1.72% | 2.23K | $37.96B | 58 | Healthcare |
|
SCLX
Scilex Holding Company
|
$13.26 | +1.30% | 48110 | 113264241 | 58 | Healthcare |
|
NVS
Novartis AG
|
$149.16 | -0.36% | 854K | 289B | 57 | Healthcare |
|
KYKOF
Kyowa Kirin Co., Ltd.
|
$12.84 | +3.38% | 1 | $6.72B | 57 | Healthcare |
|
CELG-RI
Bristol-Myers Squibb Company Ce
|
$0.11 | +3.33% | 23K | 221M | 57 | Healthcare |
|
CRXT
Clarus Therapeutics Holdings, Inc.
|
$0.05 | -31.16% | 2.74M | 0 | 56 | Healthcare |
|
BMY
Bristol-Myers Squibb Company
|
$59.31 | -0.48% | 4.05M | $120.79B | 55 | Healthcare |
|
DSKYF
Daiichi Sankyo Company, Limited
|
$18.02 | -1.61% | 964 | $33.37B | 55 | Healthcare |
|
DSNKY
Daiichi Sankyo Company, Limited
|
$18.05 | -1.55% | 7.68K | $33.40B | 55 | Healthcare |
|
ALPMY
Astellas Pharma Inc.
|
$16.46 | -0.14% | 2.27K | $29.48B | 55 | Healthcare |
|
NVSEF
Novartis AG
|
$150.00 | +3.09% | 671 | $286.22B | 55 | Healthcare |
|
CHGCF
Chugai Pharmaceutical Co., Ltd.
|
$64.01 | +14.75% | 216 | $105.34B | 55 | Healthcare |
|
CHGCY
Chugai Pharmaceutical Co., Ltd.
|
$27.81 | -3.77% | 98.56K | $91.53B | 55 | Healthcare |
|
GILD
Gilead Sciences, Inc.
|
$136.88 | -1.00% | 5M | 170B | 55 | Healthcare |
|
VRBCF
Virbac S.A.
|
$384.75 | +0.00% | 1 | $3.22B | 54 | Healthcare |
|
OPHLY
Ono Pharmaceutical Co., Ltd.
|
$5.26 | -0.59% | 8.58K | $7.41B | 54 | Healthcare |
|
RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A.
|
$56.95 | +0.00% | 2 | $11.58B | 54 | Healthcare |
|
RHHVF
Roche Holding AG
|
$403.29 | +8.69% | 2 | $321.02B | 54 | Healthcare |
|
HZNP
Horizon Therapeutics Public Limited Company
|
$116.30 | +0.00% | 23.92M | $26.60B | 54 | Healthcare |
|
JNJ
Johnson & Johnson
|
$243.04 | -0.44% | 6M | 586B | 53 | Healthcare |
|
ABBV
AbbVie Inc.
|
$205.06 | +0.06% | 3M | 363B | 52 | Healthcare |
|
CTOR
Citius Oncology, Inc.
|
$1.15 | +6.48% | 629936 | 97517523 | 52 | Healthcare |
|
GIFOF
Grifols, S.A.
|
$8.85 | +0.00% | 4.41K | $8.70B | 52 | Healthcare |
|
GIFLF
Grifols, S.A.
|
$12.90 | +0.00% | 1.20K | $8.78B | 52 | Healthcare |
|
BDSIW
BioDelivery Sciences Intl, Inc. Wrrt
|
$0.04 | -25.00% | 552.11K | 0 | 52 | Healthcare |
|
NVO
Novo Nordisk A/S
|
$38.83 | +0.28% | 14M | 173B | 51 | Healthcare |
|
BAYRY
Bayer AG
|
$11.39 | +1.15% | 9.71K | $44.76B | 51 | Healthcare |
|
HAWPY
Haw Par Corporation Limited
|
$53.50 | +0.00% | 7 | $2.96B | 50 | Healthcare |
|
BMYMP
Bristol-Myers Squibb Company PFD CONV 2
|
$400.00 | -57.46% | 13 | $814.59B | 50 | Healthcare |
|
CHJTF
CSPC Pharmaceutical Group Limited
|
$1.02 | -12.82% | 400 | $11.65B | 50 | Healthcare |
|
OGN
Organon & Co.
|
$5.98 | -1.32% | 29K | 1934112184 | 50 | Healthcare |
|
LYPHF
Luye Pharma Group Ltd.
|
$0.38 | +0.00% | 400 | $1.51B | 49 | Healthcare |
|
CMOPF
Cosmo Pharmaceuticals N.V.
|
$109.00 | -5.50% | 2.10K | $1.76B | 49 | Healthcare |
|
HAWPF
Haw Par Corporation Limited
|
$12.00 | +0.00% | 200 | $2.66B | 49 | Healthcare |
Last updated: 2026-04-06